Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505735 · ClinicalTrials.gov registry record
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 25
- Enrollment target
NCT04505735 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 25 participants.
The verdict
NCT04505735 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the amount of amyloid in the brain. Amyloid is a protein found in the brain of patients with Alzheimer's disease and can be detected using a Positron Emission Tomography (PET) scan. This study is interested in how amyloid levels in the brain relate to memory and thinking abilities.
Interventions
- DRUG 11C-PiB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-11-22 |
| Est. Completion | 2022-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04505735
The ClinicalTrials.gov registry entry for NCT04505735 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 11C-PiB is the first listed.
NCT04505735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04505735 about?
NCT04505735 is a clinical study titled "Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment". The purpose of this study is to measure the amount of amyloid in the brain. Amyloid is a protein found in the brain of patients with Alzheimer's disease and can be detected using a Positron Emission Tomography (PET) scan. This study is interested in how amyloid levels in the brain relate to memory a...
What is the current status of trial NCT04505735?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2016-11-22. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT04505735?
The interventions under investigation include: 11C-PiB (DRUG).
Who is sponsoring clinical trial NCT04505735?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.